Sarah Boyce

RNA

Sarah Boyce serves as director, officer: President and CEO at Avidity Biosciences, Inc. (RNA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

8 trades

$9.17M

Net Position

Net Seller

$9.17M

Companies Traded

RNA

Active Period

Mar 2025 – Jan 2026

8 total trades

Most Recent

Sell RNA

Jan 23, 2026 · $1.04M

Sarah Boyce's Insider Trading at Avidity Biosciences, Inc. (RNA)

Buys

0 · $0.00

Sells

8 · $9.17M

Total Shares Bought

Total Shares Sold

168,208

RNA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 23, 2026↗	Sell	14,387	$72.45	$1.04M	277,000
Jan 21, 2026↗	Sell	14,387	$72.45	$1.04M	0
Jan 9, 2026↗	Sell	8,576	$72.23	$619.4K	283,394
Jan 7, 2026↗	Sell	8,576	$72.23	$619.4K	0
Dec 17, 2025↗	Sell	15,742	$71.87	$1.13M	0
Sep 5, 2025↗	Sell	50,000	$49.95	$2.50M	0
Aug 28, 2025↗	Sell	25,000	$49.39	$1.23M	0
Mar 20, 2025↗	Sell	31,540	$31.06	$979.6K	0